Lv1
8 积分 2024-08-05 加入
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn’s Disease
1个月前
已完结
Efficacy, Safety, and Tolerability of Oral DFD-29, a Low-Dose Formulation of Minocycline, in Rosacea
5个月前
已完结
A propensity-score matching analysis comparing long-term survival of surgery alone and postoperative treatment for patients in node positive or stage III esophageal squamous cell carcinoma after R0 esophagectomy
6个月前
已完结
皖公网安备34019202002308
